Obesity Funding, AI and Clinical Trial Diversity: Where The NIH Director Nominee Stands

Monica Bertagnolli’s Senate HELP confirmation hearing did not produce many displays of bipartisanship, but it did illuminate many of the key challenges facing NIH on topics that impact pharma companies.

Sign for NIH building
The Senate HELP committee vetted NIH Director Nominee Monica Bertagnolli on 18 October. • Source: Shutterstock

Increasing the US National Institutes of Health’s funding of obesity research was one of the only areas of bipartisan agreement among the Senate Health Committee leaders at the 18 October hearing for Monica Bertagnolli to lead the NIH.

Bertagnolli agreed with Chair Bernie Sanders, I-VT, and Ranking Member Bill Cassidy, R-LA, of the importance of this topic, but her vision of how to allocate obesity funding

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from United States

More from North America